Ohio State Cancer Expert Appointed to National Dietary Guidelines Advisory Committee

June 05, 2013

COLUMBUS, Ohio –Steven Clinton,MD, PhD, program leader of molecular carcinogenesis and chemoprevention at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), has been appointed to serve on the national 2015 Dietary Guidelines Advisory Committee.

Clinton was appointed along with 14 other nationally recognized experts to serve on the committee by The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA). The committee’s recommendations and rationale will serve as a basis for the eighth edition of the Dietary Guidelines for Americans.

Clinton’s research focuses on nutrition and cancer, with experience in epidemiology, clinical trials, community research, and experimental models, as well as cell and molecular systems. He has published extensively on the role of dietary energy balance in cancer risk, on a variety of foods with cancer prevention properties, as well as on several nutrients including vitamin D, calcium, and omega-3 fatty acids. He served on the Institute of Medicine’s (IOM) Committee on Dietary Reference Intakes for Vitamin D and Calcium.

The Dietary Guidelines serve as the foundation for national nutrition programs, standards and education. They also provide the key recommendations for the general population as well as specific population groups to help people choose an overall healthy diet that works for them. These guidelines are updated every five years.

The inaugural meeting of the Committee is scheduled for June 13-14, 2013 and will be open to the public.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 228-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.

###

Click here for a high-quality photo of Dr. Steven Clinton.

Contact: Alexis Shaw, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, Alexis.Shaw2@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Cell Therapy Offers New Way to Treat Certain Cancers

The research and medical experts at The James are using something called cell therapy to treat some cancers as well as find new ways treat others.

CanDL Database Shines Light on Clinically Important Cancer Gene Mutations

To help molecular pathologists, laboratory directors, bioinformaticians and oncologists identify key mutations that drive tumor growth in tissues obtained during clinical studies, researchers at the...

Where Patients Reign Supreme

At the OSUCCC – James, our cancer program’s chief aim is quality clinical care.